The Prostate · 1983 · 11 citations · 20 references
MedicineOncologyUrologyGenitourinary OncologyMetastasisProstate DiseaseBenign Prostatic HyperplasiaBiomarkers In Genitourinary CancerBiomarkers In Urologic OncologyProstate CancerProstatic PathologyUrologic Cancer DiagnosisBiomarkers For Metastatic DiseaseHydroxyproline ContentMetastatic Prostatic CarcinomaProstate Cancer DiagnosisProstate Tumor MarkersProstatic BiomarkersTumor Marker AnalysisTumor Marker Assays
Urinary hydroxyproline/creatinine ratio was measured in 49 patients of prostatic carcinoma and 13 patients with benign prostatic hypertrophy, the latter group serving as controls. The results show that it is a very sensitive indicator of osseous metastases in prostatic carcinoma. The ratio was also measured in 18 patients of prostatic carcinoma with bony metastases before commencement of treatment and during treatment. The results show that the elevated pretreatment values were significantly reduced in those who responded to therapy whereas in nonresponders, the values remained high. Changes in urinary hydroxyproline appeared to reflect the nature of response to treatment better than other parameters.
20
Metastases from testicular carcinoma Study of 78 autopsied cases
Douglas E. Johnson, G. Appelt, M. L. Samuels et al. · Urology · 1976 · 204 citations
Urinary hydroxyproline excretion in patients with cancer
Carlos E. Guzzo, Willy N. Pachas, Robert S. Pinals et al. · Cancer · 1969 · 63 citations · Full text
Michael Henneberry, Geoffrey Engel, John T. Grayhack · Urologic Clinics of North America · 1979 · 55 citations